Urgent new medical advice has prompted the federal government to “recalibrate” its coronavirus vaccine strategy, likely delaying the rollout even further.
Most Australians under 50 will no longer be recommended to use the AstraZeneca coronavirus vaccine because of concerns around blood clots, a rare side effect from that product.
Prime Minister Scott Morrison called a late press conference on Thursday to announce the change, based on advice from The Australian Technical Advisory Group on Immunisation (ATAGI).
Health Secretary Brendan Murphy broke down what the new advice would mean for the vaccination program.
“For phase one, which is vulnerable people, we will pretty much continue as we are,” he said.
“Those over 70 and 80 will…